The discovery and development of zileuton : an orally active 5-lipoxygenase inhibitor
- Author
- BELL, R. L; YOUNG, P. R; ALBERT, D; LANNI, C; SUMMERS, J. B; BROOKS, D. W; RUBIN, P; CARTER, G. W
Abbott Laboratories, immunosci. res. area immunosci. venture, Abbott Park IL 60064, United States - Conference title
- International conference on immunopharmacology
- Conference name
- International conference on immunopharmacology (5 ; Tampa FL 1991-05-26)
- Author (monograph)
- International Society for Immunopharmacology, International (Funder/Sponsor)
Tampa Convention Center, Tampa FL, United States (Funder/Sponsor) - Source
International journal of immunopharmacology. 1992, Vol 14, Num 3, pp 505-510 ; ref : 1 p. 1/4
- CODEN
- IJIMDS
- ISSN
- 0192-0561
- Scientific domain
- Immunology, immunopathology, allergology; Pharmacology drugs
- Publisher
- Elsevier Science, Oxford
- Publication country
- United Kingdom
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- Activité biologique Animal Antiinflammatoire Arachidonique acide dérivé Biosynthèse Homme Inhibiteur enzyme Inhibition Leucotriène Lipoxygenase Recherche développement Voie orale Zileuton Enzyme
- Keyword (en)
- Biological activity Animal Antiinflammatory agent Arachidonic acid derivatives Biosynthesis Human Enzyme inhibitor Inhibition Leukotriene Lipoxygenase Research and development Oral administration Enzyme
- Keyword (es)
- Actividad biológica Animal Antiinflamatorio Araquidónico ácido derivado Biosíntesis Hombre Inhibidor enzima Inhibición Leucotrieno Lipoxygenase Investigación desarrollo Vía oral Enzima
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02D Respiratory system
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 5297959
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/0192-0561(92)90182-K 
https://dx.doi.org/10.1016/0192-0561(92)90182-K
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0192-0561(92)90182-K\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"The discovery and development of zileuton : an orally active 5-lipoxygenase inhibitor\";s:9:\"\u0000*\u0000jtitle\";s:43:\"International journal of immunopharmacology\";s:9:\"\u0000*\u0000stitle\";s:23:\"Int. j. immunopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"505\";s:8:\"\u0000*\u0000epage\";s:3:\"510\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0192-0561\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BELL\";s:10:\"\u0000*\u0000aufirst\";s:4:\"R. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"YOUNG, P. R\";i:1;s:9:\"ALBERT, D\";i:2;s:8:\"LANNI, C\";i:3;s:13:\"SUMMERS, J. B\";i:4;s:12:\"BROOKS, D. W\";i:5;s:8:\"RUBIN, P\";i:6;s:12:\"CARTER, G. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJIMDS\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:46:\"International conference on immunopharmacology\";s:8:\"\u0000*\u0000title\";s:85:\"The discovery and development of zileuton : an orally active 5-lipoxygenase inhibitor\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0192-0561(92)90182-K\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"The discovery and development of zileuton : an orally active 5-lipoxygenase inhibitor\";s:9:\"\u0000*\u0000jtitle\";s:43:\"International journal of immunopharmacology\";s:9:\"\u0000*\u0000stitle\";s:23:\"Int. j. immunopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"505\";s:8:\"\u0000*\u0000epage\";s:3:\"510\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0192-0561\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BELL\";s:10:\"\u0000*\u0000aufirst\";s:4:\"R. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"YOUNG, P. R\";i:1;s:9:\"ALBERT, D\";i:2;s:8:\"LANNI, C\";i:3;s:13:\"SUMMERS, J. B\";i:4;s:12:\"BROOKS, D. W\";i:5;s:8:\"RUBIN, P\";i:6;s:12:\"CARTER, G. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJIMDS\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:46:\"International conference on immunopharmacology\";s:8:\"\u0000*\u0000title\";s:85:\"The discovery and development of zileuton : an orally active 5-lipoxygenase inhibitor\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0192-0561(92)90182-K\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0192-0561(92)90182-K\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"The discovery and development of zileuton : an orally active 5-lipoxygenase inhibitor\";s:9:\"\u0000*\u0000jtitle\";s:43:\"International journal of immunopharmacology\";s:9:\"\u0000*\u0000stitle\";s:23:\"Int. j. immunopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"505\";s:8:\"\u0000*\u0000epage\";s:3:\"510\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0192-0561\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BELL\";s:10:\"\u0000*\u0000aufirst\";s:4:\"R. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"YOUNG, P. R\";i:1;s:9:\"ALBERT, D\";i:2;s:8:\"LANNI, C\";i:3;s:13:\"SUMMERS, J. B\";i:4;s:12:\"BROOKS, D. W\";i:5;s:8:\"RUBIN, P\";i:6;s:12:\"CARTER, G. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJIMDS\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:46:\"International conference on immunopharmacology\";s:8:\"\u0000*\u0000title\";s:85:\"The discovery and development of zileuton : an orally active 5-lipoxygenase inhibitor\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0192-0561(92)90182-K\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"The discovery and development of zileuton : an orally active 5-lipoxygenase inhibitor\";s:9:\"\u0000*\u0000jtitle\";s:43:\"International journal of immunopharmacology\";s:9:\"\u0000*\u0000stitle\";s:23:\"Int. j. immunopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"505\";s:8:\"\u0000*\u0000epage\";s:3:\"510\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0192-0561\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BELL\";s:10:\"\u0000*\u0000aufirst\";s:4:\"R. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"YOUNG, P. R\";i:1;s:9:\"ALBERT, D\";i:2;s:8:\"LANNI, C\";i:3;s:13:\"SUMMERS, J. B\";i:4;s:12:\"BROOKS, D. W\";i:5;s:8:\"RUBIN, P\";i:6;s:12:\"CARTER, G. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJIMDS\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:46:\"International conference on immunopharmacology\";s:8:\"\u0000*\u0000title\";s:85:\"The discovery and development of zileuton : an orally active 5-lipoxygenase inhibitor\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/0192-0561(92)90182-K\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"The discovery and development of zileuton : an orally active 5-lipoxygenase inhibitor\";s:9:\"\u0000*\u0000jtitle\";s:43:\"International journal of immunopharmacology\";s:9:\"\u0000*\u0000stitle\";s:23:\"Int. j. immunopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"505\";s:8:\"\u0000*\u0000epage\";s:3:\"510\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0192-0561\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BELL\";s:10:\"\u0000*\u0000aufirst\";s:4:\"R. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"YOUNG, P. R\";i:1;s:9:\"ALBERT, D\";i:2;s:8:\"LANNI, C\";i:3;s:13:\"SUMMERS, J. B\";i:4;s:12:\"BROOKS, D. W\";i:5;s:8:\"RUBIN, P\";i:6;s:12:\"CARTER, G. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJIMDS\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:46:\"International conference on immunopharmacology\";s:8:\"\u0000*\u0000title\";s:85:\"The discovery and development of zileuton : an orally active 5-lipoxygenase inhibitor\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
